On 2023-08-11, Sorrento Therapeutics, Inc. (SRNE) announced earnings per share of $-0.17 for the fiscal quarter ending 2023-06-30, missing the average analyst estimate of $-0.15.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2023-08-11 | 2023-06-30 | $-0.15 | $-0.17 |
| 2023-05-15 | 2023-03-31 | $-0.16 | $-0.26 |
| 2022-11-08 | 2022-09-30 | $-0.25 | $-0.20 |
| 2022-08-15 | 2022-06-30 | $-0.23 | $-0.31 |
| 2022-05-05 | 2022-03-31 | -- | $-0.12 |
| 2021-11-05 | 2021-09-30 | $-0.21 | $-0.40 |
| 2021-08-06 | 2021-06-30 | $-0.20 | $-0.33 |
| 2021-05-05 | 2021-03-31 | $0.24 | $0.01 |
| 2021-02-19 | 2020-12-31 | $-0.22 | $-0.27 |
| 2020-11-06 | 2020-09-30 | $-0.25 | $-0.33 |
| 2020-08-04 | 2020-06-30 | $-0.24 | $-0.22 |
| 2020-05-11 | 2020-03-31 | $-0.20 | $-0.26 |
| 2020-03-02 | 2019-12-31 | $-0.41 | $-0.41 |
| 2019-11-08 | 2019-09-30 | $-0.42 | $-0.42 |
| 2019-08-09 | 2019-06-30 | $-0.40 | $-0.39 |
| 2019-05-15 | 2019-03-31 | $-0.35 | $-0.30 |
| 2019-03-15 | 2018-12-31 | -- | $-0.40 |
| 2018-11-09 | 2018-09-30 | -- | $-0.40 |
| 2018-08-09 | 2018-06-30 | $-0.20 | $-0.73 |
| 2018-05-10 | 2018-03-31 | -- | $-0.38 |
| 2018-03-16 | 2017-12-31 | -- | $0.72 |
| 2017-11-09 | 2017-09-30 | -- | $0.44 |
| 2017-08-09 | 2017-06-30 | -- | $-0.20 |
| 2017-05-15 | 2017-03-31 | $-0.33 | $-0.45 |
| 2017-03-21 | 2016-12-31 | $-0.27 | $-0.44 |
| 2016-11-09 | 2016-09-30 | -- | $-0.19 |
| 2016-08-08 | 2016-06-30 | $-0.17 | $-0.28 |
| 2016-05-10 | 2016-03-31 | $-0.37 | $-0.63 |
| 2016-03-15 | 2015-12-31 | -- | $-0.63 |
| 2015-11-16 | 2015-09-30 | $-0.37 | $-0.82 |
| 2015-08-07 | 2015-06-30 | $-0.32 | $-0.30 |
| 2015-05-05 | 2015-03-31 | $-0.14 | $-0.29 |
| 2015-03-13 | 2014-12-31 | -- | $-0.28 |